We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker.AuthorsMunster PN; Marchion D; Thomas S; Egorin M; Minton S; Springett G; Lee JH; Simon G; Chiappori A; Sullivan D; Daud APublicationBritish journal of cancer, 2009, Vol 101, Issue 7, p1044ISSN1532-1827Publication typearticleDOI10.1038/sj.bjc.6605293